XML 32 R10.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Available for Sale Securities
12 Months Ended
Jun. 30, 2024
Available for Sale Securities  
Available for Sale Securities

NOTE 2: Available for Sale Securities

The amortized cost, gross unrealized gains, gross unrealized losses and approximate fair value of securities available for sale consisted of the following:

June 30, 2024

 

 

Gross

 

Gross

 

Allowance

Estimated

 

Amortized

 

Unrealized

 

Unrealized

 

for

 

Fair

(dollars in thousands)

    

Cost

    

Gains

    

Losses

    

Credit Losses

    

Value

Debt securities:

Obligations of states and political subdivisions

$

29,960

$

4

$

(2,211)

$

$

27,753

Corporate obligations

32,998

60

(1,781)

31,277

Asset-backed securities

57,403

1,525

(249)

58,679

Other securities

 

5,387

 

20

 

(74)

 

 

5,333

Total debt securities

125,748

1,609

(4,315)

123,042

Mortgage-backed securities (MBS) and collateralized mortgage obligations (CMOs):

Residential MBS issued by governmental sponsored enterprises (GSEs)

110,918

692

(6,855)

104,755

Commercial MBS issued by GSEs

65,195

297

(5,746)

59,746

CMOs issued by GSEs

148,382

82

(8,104)

140,360

Total MBS and CMOs

 

324,495

 

1,071

 

(20,705)

 

304,861

Total AFS securities

$

450,243

$

2,680

$

(25,020)

$

$

427,903

June 30, 2023

 

 

Gross

 

Gross

Allowance

Estimated

 

Amortized

 

Unrealized

 

Unrealized

 

for

 

Fair

(dollars in thousands)

    

Cost

    

Gains

    

Losses

    

Credit Losses

    

Value

Debt securities:

Obligations of states and political subdivisions

$

45,285

$

20

$

(2,737)

$

$

42,568

Corporate obligations

35,700

19

(3,181)

32,538

Asset-backed securities

67,897

1,274

(545)

68,626

Other securities

3,587

 

39

 

(56)

 

3,570

Total debt securities

152,469

1,352

(6,519)

147,302

MBS and CMOs

Residential MBS issued by governmental sponsored enterprises (GSEs)

97,612

122

(7,610)

90,124

Commercial MBS issued by GSEs

60,333

11

(6,959)

53,385

CMOs issued by GSEs

135,202

9

(8,468)

126,743

Total MBS and CMOs

 

293,147

 

142

 

(23,037)

 

 

270,252

Total AFS securities

$

445,616

$

1,494

$

(29,556)

$

$

417,554

The amortized cost and fair value of available-for-sale securities, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.

June 30, 2024

 

Amortized

 

Estimated

(dollars in thousands)

    

Cost

    

Fair Value

Within one year

$

1,452

$

1,438

After one year but less than five years

 

26,898

 

26,039

After five years but less than ten years

 

50,306

 

48,237

After ten years

 

47,092

 

47,328

Total investment securities

 

125,748

 

123,042

MBS and CMOs

 

324,495

 

304,861

Total AFS securities

$

450,243

$

427,903

The carrying value of investment and mortgage-backed securities pledged as collateral to secure public deposits amounted to $265.5 million and $253.9 million at June 30, 2024 and 2023, respectively. The securities pledged consist of marketable securities, including $137.0 million and $129.2 million of MBS, $103.5 million and $94.8 million of CMOs, $20.8 million and $26.5 million of State and Political Subdivisions Obligations, and $4.3 million and $3.4 million of Other Securities at June 30, 2024 and 2023, respectively.

Gross gains of $67,000 and gross losses of $1.6 million were recognized from sales of available-for-sale securities in fiscal 2024. There were no gains or losses recognized from sales of available-for-sale securities in fiscal 2023 or 2022.

The Company did not hold any securities of a single issuer, payable from and secured by the same source of revenue or taxing authority, the book value of which exceeded 10% of stockholders’ equity at June 30, 2024.

Certain investments in debt securities are reported in the consolidated financial statements at an amount less than their historical cost. Total fair value of these investments at June 30, 2024, was $312.9 million, which is approximately 73.1% of the Company’s AFS investment portfolio, as compared to $325.5 million or approximately 78.0% of the Company’s AFS investment portfolio at June 30, 2023. Management believes the declines in fair value for these securities to be temporary.

The following tables below show the Company’s investments’ gross unrealized losses and fair value, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for which ACL has not been recorded at June 30, 2024 and 2023.

 

Less than 12 months

 

12 months or more

 

Total

 

Unrealized

 

Unrealized

 

Unrealized

(dollars in thousands)

    

Fair Value

    

Losses

    

21,762

    

Losses

    

Fair Value

    

Losses

For the year ended June 30, 2024

Obligations of state and political subdivisions

$

3,720

$

38

$

21,762

$

2,173

$

25,482

$

2,211

Corporate obligations

25,295

1,781

25,295

1,781

Asset-backed securities

7,234

249

7,234

249

Other securities

4,404

31

287

43

4,691

74

MBS and CMOs

 

56,820

 

621

 

193,382

 

20,084

 

250,202

 

20,705

Total AFS securities

$

64,944

$

690

$

247,960

$

24,330

$

312,904

$

25,020

 

Less than 12 months

 

12 months or more

 

Total

 

Unrealized

 

Unrealized

 

Unrealized

(dollars in thousands)

    

Fair Value

    

Losses

    

Fair Value

    

Losses

    

Fair Value

    

Losses

For the year ended June 30, 2023

Obligations of state and political subdivisions

$

11,574

$

184

$

26,763

$

2,553

$

38,337

$

2,737

Corporate obligations

14,709

1,074

13,821

2,107

28,530

3,181

Asset-backed securities

22,628

263

698

282

23,326

545

Other securities

1,970

11

350

45

2,320

56

MBS and CMOs

 

87,354

 

1,525

 

145,673

 

21,512

 

233,027

 

23,037

Total AFS securities

$

138,235

$

3,057

$

187,305

$

26,499

$

325,540

$

29,556

Obligations of state and political subdivisions. The unrealized losses on the Company’s investments in obligations of state and political subdivisions include eight individual securities which have been in an unrealized loss position for less than 12 months and 46 individual securities which have been in an unrealized loss position for more than 12 months. The securities are performing and are of high credit quality. The unrealized losses were caused by increases in market interest rates since purchase or acquisition. Because the Company does not intend to sell these securities and it is more likely than not that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

Corporate and other Obligations. The unrealized losses on the Company’s investments in corporate obligations include one individual securities which have been in an unrealized loss position for less than 12 months and 19 individual securitie which has been in an unrealized loss position for more than 12 months. The securities are performing. The unrealized losses were caused by increases in market interest rates since purchase or acquisition. Because the Company does not intend to sell these securities and it is more likely than not that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

Asset-Backed securities. The unrealized losses on the Company’s investments in asset-backed securities includes no individual securities which have been in an unrealized loss position for less than 12 months and four individual securities which have been in an unrealized loss position for more than 12 months. The securities are performing and are of high credit quality. The unrealized loss was caused by variations in market interest rates and spreads since purchase or acquisition. Because the Company does not intend to sell these securities and it is more likely than not that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

MBS and CMOs. As of June 30, 2024, the unrealized losses on the Company’s investments in MBS and CMOs include 16 individual securities which have been in an unrealized loss position for less than 12 months, and 114 individual securities which have been in an unrealized loss position for 12 months or more. The securities are performing and are of high credit quality. The unrealized losses were caused by increases in market interest rates since purchase or acquisition. Because the Company does not intend to sell these securities and it is more likely than not that the Company will not be required to sell these securities prior to recovery of their amortized cost basis, which may be maturity, the Company has not recorded an ACL on these securities.

The Company does not believe that any individual unrealized loss as of June 30, 2024 is the result of a credit loss. However, the Company could be required to recognize an ACL in future periods with respect to its available for sale investment securities portfolio.

Credit losses recognized on investments. There were no credit losses recognized in income and other losses or recorded in other comprehensive income (loss) for the fiscal years ended June 30, 2024 and 2023.